Schachter J. , Caldwell H.D.Chlamydiae. Annu Rev Microbiol1980; 34: 285-309.
2.
Storz J. Chlamydia and chlamydia-induced diseases. Springfield, IL, USA: Charles C. Thomas, 1991.
3.
Caldwell H.D. , Kromhout J., Schachter J.Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis . Infect Immun1981; 31: 1161-1176.
4.
Newhall W.J. , Terho V.P., Wilde III C.E. et al. Serovar determination of Chlamydia trachomatis isolates using type-specific monoclonal antibodies . J Clin Microbiol1986 ; 23: 333-338.
5.
Stephens R.S. , Tam M.R., Kuo C. et al. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization . J Immunol1982; 128: 1083-1089.
6.
Wang S.P., Barnes R.C., Stephens R.S. et al. Immunotyping of Chlamydia trachomatis with monoclonal antibodies . J Infect Dis1985; 152: 791-800.
7.
Allan I., Cunningham T.M., Lovett M.Molecular cloning of the of the major outer membrane protein of Chlamydia trachomatis. Infect Immun1984; 45: 637-641.
8.
Baehr W., Zhang Y., Joseph T. et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA1988; 85: 4000-4004.
9.
Stephens R.S. , Kuo C-C., Newport G. et al. Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in E. coli . Infect Immun1985; 47: 713-718.
10.
Schachter J. , Dawson C.R.The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis1990; 69 (Suppl.): 55-62.
11.
Grayston J.T. , Kuo C-C., Wang S-P. et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med1986; 315: 161-168.
12.
Grayston J.T. , Aldous M.B., Easton A. et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis1993; 168: 1231-1235.
13.
Dalhoff K., Maass M.Chlamydia pneumoniae pneumonia in hospitalized patients - clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL. Chest1996; 110: 351-356.
14.
Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T.Chlamydia pneumoniae (TWAR). Clin Microbiol Rev1995; 8: 451-461.
15.
Grayston J.T.Chlamydia pneumoniae (TWAR) infections in children . Pediatr Infect Dis J1994; 13: 675-685.
16.
Barenfanger J., MacDonald A.B.The role of immunoglobulin in the neutralization of trachoma infectivity. J Immunol1974 ; 113: 1607-1617.
17.
Zhang Y-X., Stewart S., Joseph T. et al. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol1987 ; 138: 575-581.
18.
Grayston J.T. , Wang S-P., Yeh L-S. et al. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis1985 ; 7: 717-725.
19.
Watkins N.G. , Hadlow WJ, Moss A.B. et al. Ocular delayed hypersensitivity: a pathogenic mechanism of chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci USA1986; 83: 7480-7484.
20.
Morrison R.P. , Belland R.J., Lyng K. et al. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med1989; 170: 1271-1283.
21.
Morrison R.P. , Lyng K., Caldwell H.D.Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med1989; 169: 663-675.
22.
Toye B., Laferrière C., Claman P. et al. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis1993; 168: 1236-1240.
23.
Hahn D.L., Dodge R.W., Golubjatnikov R.Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA1991; 266: 225-230.
24.
Sieper J., Braun J., Brandt J. et al. Pathogenic role of Chlamydia, Yersinia, amd Borrelia in undifferentiated oligoarthritis. J Rheumatol1992; 19: 1236-1242.
25.
Keat A., Thomas B.J., Dixey J. et al. Chlamydia trachomatis and reactive arthritis: the missing link . Lancet1983; 1: 72-74.
26.
Keat A., Thomas B.J., Taylor-Robinson D.Chlamydial infection in the aetiology of arthritis. Br Med Bull1983; 39: 168-174.
27.
Rietschel E.T. , Kirikae T., Schade F.U. et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J1994; 8: 217-225.
28.
Ulevitch R.J. , Tobias P.S.Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol1995 ; 13: 437-457
29.
Saikku P., Mattila K., Nieminen M.S. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease. Lancet1988; 2: 983-986.
30.
Linnanmäki E., Leinonen M., Mattila K. et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease . Circulation1993; 87: 1130-1134.
31.
Kuo C., Gown A.M., Benditt E.P. et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb1993; 13: 1501-1504.
32.
Kuo C-C., Shor A., Campbell L.A. et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis1993; 167: 841-849.
33.
Campbell L.A. , Moazed T.C., Kuo C-C., Grayston J.T.Mouse models of atherosclerosis and Chlamydia pneumoniae infection. In: Stary A. Ed. Proceedings Third Meeting of the European Society for Chlamydia Research Bologna, Italy: Societa Editrice Esculapio1996: 106.
34.
Moulder J.W.Interaction of Chlamydiae and host cells in vitro. Microbiol Rev1991; 55: 143-190.
35.
Kuo C-C., Grayston J.T., Campbell L.A., Goo Y.A., Wissler R.W., Benditt E.P.Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA1995; 92: 6911-6914.
36.
Kingsbury D.T. , Weiss E.Lack of deoxyribonucleic acid homology between species of the genus Chlamydia. J Bacteriol1968; 96: 1421-1423.
37.
Gaydos C.A. , Palmer L., Quinn T.C. et al. Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences. Int J Syst Bacteriol1993 ; 43: 610-612.
Hatch T.P.Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae?J Bacteriol1996 ; 178: 1-5.
41.
Barbour A.G. , Amato K.L., Hackstadt T. et al. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol1982 ; 151: 420-428.
42.
Zhang J.P., Stephens R.S.Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell1992; 69: 861-869.
43.
Matsumoto A. , Manire G.P.Electron microscopic observations on the effect of penicillin on the morphology of Chlamydia psittaci. J Bacteriol1970; 101: 278-285.
44.
Byrne G.L., Lehmann L.K., Landry G.J.Induction of tryptophane catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun1986; 53: 347-351.
45.
Shemer-Avni Y., Wallach D., Sarov I.Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun1988; 56: 2503-2506.
46.
Stephens R.S.Chlamydial genomic sequencing and manipulation. In: Stary A. Ed. Proceedings Third Meeting of the European Society for Chlamydia Research Bologna, Italy: Societa Editrice Esculapio, 1996; 7-10.
47.
Richmond S.J. , Stirling P., Ashley C.R.Virus infecting the reticulate bodies of an avian strain of Chlamydia psittaci. FEMS Microbiol Lett1982; 14: 31-36.
48.
Palmer L., Falkow S.A common plasmid of Chlamydia trachomatis. Plasmid1986; 16: 62.
49.
Wenman W.M. , Lovett M.A.Expression in E. coli of Chlamydia trachomatis antigen recognized during human infection. Nature1982; 269: 68-70.
50.
Bedson S.P.Observations bearing on the antigenic composition of psittacosis virus. Br J Exp Pathol1936 ; 17: 109-121.
51.
Dhir S.P., Hakomori S., Kenny G.E. et al. Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol1972; 109: 116-122.
52.
Nurminen M. , Leinonen M., Saikku P. et al. The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria . Science1993; 220: 1279-1281.
53.
Brade H., Brunner H.Serological cross-reactions between Acinetobacter calcoaceticus and Chlamydiae . J Clin Microbiol1979; 10: 819-822.
54.
Matthiesen M.Studies on ornithosis-related antigen from Bacterium anitratum. Bacterium anitratum and its ability to produce the ornithosis-related antigen. Acta Pathol Microbiol Scand1957; 41: 247-256.
55.
Matthiesen M., Volkert M.The antigenic relationship between ornithosis virus and Bacterium anitratum. Acta Pathol Microbiol Scand1957; 41: 135-143.
56.
Volkert M., Matthiesen M.An ornithosis related antigen from a coccoid bacterium. Acta Pathol Microbiol Scand1956; 39: 117-126.
57.
Brade H., Brunner H.Detection of chlamydial inclusion bodies with antisera to Acinetobacter calcoaceticus subsp. anitratus by indirect immunofluorescence. Infection1980; 8: 215-216.
58.
Nurminen M. , Rietschel E.T., Brade H.Chemical characterization of Chlamydia trachomatis lipopolysaccharide. Infect Immun1985; 48: 573-575.
59.
Brade L., Schramek S., Schade U. et al. Chemical, biological, and immunochemical properties of the lipopolysaccharide of Chlamydia psittaci. Infect Immun1986; 54: 568-574.
60.
Brade L., Nurminen M., Mäkelä P.H. et al. Antigenic properties of Chlamydia trachomatis lipopolysaccharide . Infect Immun1985; 48: 569-572.
61.
Kuhn H-M., Brade L., Appelmelk B.J., Kusomoto S., Rietschel E.T., Brade H.Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun1992 ; 60: 2201-2210.
62.
Holst O., Brade H.The chemical structure of core oligosaccharides. In: Morrison D.C., Ryan J.L. Eds Bacterial endotoxic lipopolysaccharides, Vol 1, Molecular biochemistry and cellular biology. Boca Raton, FL, USA: CRC Press, 1992; 135-170.
63.
Brade H., Rietschel E.T.α-2→4-Interlinked 3-deoxy-D-manno-octulosonic acid disaccharide: a common constituent of enterobacterial lipopolysaccharides. Eur J Biochem1984; 145: 231-236.
64.
Brade H., Zähringer U., Rietschel E.T. et al. Spectroscopic analysis of a 3-deoxy-D-manno-2-octulosonic acid (KDO) disaccharide from the lipopolysaccharide of a Salmonella godesberg Re-mutant . Carbohydr Res1984; 134: 157-166.
65.
Brade L., Holst O., Kosma P. et al. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect Immun1990; 58: 205-213.
66.
Brade L., Kosma P., Appelmelk B.J. et al. Use of synthetic antigens to determine the epitope specificity of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide. Infect Immun1987; 55: 462-466.
67.
Rozalski A. , Brade L., Kosma P. et al. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re-chemotype. Infect Immun1989; 57: 2645-2652.
68.
Rozalski A. , Brade L., Kuhn H-M. et al. Epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide. Carbohydr Res1990; 193: 257-270.
69.
Kosma P., Bahnmüller R., Schulz G. et al. Synthesis of a tetrasaccharide hapten related to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res1990; 208: 37-50.
70.
Kosma P., Schulz G., Brade H.Synthesis of a trisaccharide of 3-deoxy-D-manno-2-octulopyranosylonic acid (KDO) residues related to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res1988; 183: 183-199.
71.
Kosma P., Schulz G., Unger F.M. et al. Synthesis of trisaccharides containing 3-deoxy-D-manno-2-octulosonic acid residues related to the KDO-region of enterobacterial lipopolysaccharides . Carbohydr Res1989; 190: 191-201.
72.
Kosma P., Strobl M., Allmaier G. et al. Synthesis of pentasaccharide core structures corresponding to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res1994; 254: 105-132.
73.
Caldwell H.D. , Hitchcock P.J.Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide . Infect Immun1984; 44: 306-314.
74.
Nano F.E., Caldwell H.D.Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science1985; 228: 742-744.
75.
Brade L.Nano F.E., Schlecht S. et al. Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific epitope of Chlamydiae. Infect Immun1987; 55: 482-486.
76.
Brade H., Brade L., Nano F.E.Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci USA1987; 84: 2508-2512.
77.
Holst O., Brade H., Kosma P.G.l.c.-m.s. of reduced, acetylated, and methylated (2→4)- and (2→8)-linked disaccharides of 3-deoxy-D-manno-2-octulopyranosonic acid (Kdo). Carbohydr Res1992; 231: 65-71.
78.
Holst O., Brade L., Kosma P. et al. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia. J Bacteriol1991; 173: 1862-1866.
79.
Holst O., Broer W., Thomas-Oates J.E. et al. Structural analysis of two oligosaccharide bisphosphates isolated from a recombinant strain of Escherichia coli F515 (Re chemotype) expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem1993; 214: 703-710.
80.
Holst O., Bock K., Brade L., Brade H.The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC. Eur J Biochem1995; 229: 194-200.
81.
Holst O., Thomas-Oates J.E., Brade H.Preparation and structural analysis of oligosaccharide monophosphates obtained from the lipopolysaccharides of recombinant strains of Salmonella minnesota and Escherichia coli expressing the genus-specific epitope of Chlamydia lipopolysaccharide . Eur J Biochem1994; 222: 183-194.
82.
Fu Y., Baumann M., Kosma P. et al. A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same immunoreactivity as its natural counterpart. Infect Immun1992; 60: 1314-1321.
83.
Mäkelä P.H., Stocker B.D.A.Genetics of lipopolysaccharide. In: Proctor R.A. Ed. Handbook of Endotoxins, Vol. 1. Amsterdam: Elsevier , 1994; 59-137.
84.
Schnaitman C.A., Klena J.D.Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev1993; 57: 655-682.
85.
Woisetschläger M., Högenauer G.Cloning and characterization of the gene encoding 3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase from Escherichia coli . J Bacteriol1986 ; 168: 437-439.
86.
Goldman R.C. , Kohlbrenner W.E.Molecular cloning of the structural gene coding for CTP:CMP-3-deoxy-mannooctulosonate cytidyltransferase from Escherichia coli K- 12. J Bacteriol1985 ; 163: 256-261.
87.
Woisetschläger M., Högenauer G.Cloning and characterization of the gene encoding 3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase from Escherichia coli . J Bacteriol1986 ; 168: 437-439.
88.
Brabetz W., Brade H.Molecular cloning, sequence analysis, and functional characterization of the gene kdsA, encoding 3-deoxy-α-D-manno-octulosonate-8-phosphate synthase of Chlamydia psittaci 6BC. Eur J Biochem1997 ; In press.
89.
Clementz T. , Raetz C.R.H. A gene coding for 3-deoxy-D-manno-octulosonic acid transferase from Escherichia coli. J Biol Chem1991; 266: 9687-9696.
90.
Belunis C.J. , Mdluli K.E., Raetz C.R.H. et al. A novel 3-deoxy-D-manno-octulosonic acid transferase from Chlamydia trachomatis required for expression of the genus-specific epitope. J Biol Chem1992; 267: 18702-18707.
91.
Mamat U., Baumann M., Schmidt G. et al. The genus-specific lipopolysaccharide epitope of Chlamydia is assembled in C. psittaci and C. trachomatis by glycosyl-transferases of low homology. Mol Microbiol1993; 10: 935-941.
92.
Löbau S., Mamat U., Brabetz W., Brade H.Molecular cloning, sequence analysis, and functional characterization of the lipopolysaccharide biosynthetic gene kdtA encoding 3-deoxy-α-D-manno-octulosonic acid transferase of Chlamydia pneumoniae strain TW-183. Mol Microbiol1995 ; 18: 391-399.
93.
Karimi S.T. , Schloemer R.H., Wilde III C.E.Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect Immun1989; 57: 1780-1785.
94.
Richmond S.J. , Stirling P.Localization of chlamydial group antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaci . Infect Immun1981; 34: 561-570.
95.
Ingalls R.R. , Rice P.A., Qureshi N., Takayama K., Lin J.S., Golenbock D.T.The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated . Infect Immun1995; 63: 3125-3130.
96.
Campbell S., Richmond S.J., Yates P.S. et al. Lipopolysaccharide in cells infected by Chlamydia trachomatis . Microbiol1994 ; 140: 1995-2002.
97.
Baumann M., Brade L., Fasske E. et al. Staining of surface antigens of Chlamydia trachomatis L2 in tissue culture. Infect Immun1992; 60: 4433-4438.
98.
Birkelund S. , Lundemose A.G., Christiansen G.Immunoelectron microscopy of lipopolysaccharide in Chlamydia trachomatis. Infect Immun1987; 57: 3250-3253.
99.
Lukácová M., Baumann M., Brade L. et al. Lipopolysaccharide smooth/rough phase variation in bacteria of the genus Chlamydia. Infect Immun1994; 62: 2270-2276.
100.
Vinogradov E.V., Pantophlet R., Dijkshoorn L., Brade L., Holst O., Brade H.Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter . Eur J Biochem1996; 239: 602-610.
101.
Moran A., Appelmelk B.J., Aspinall G.O.Resistance of Serratia marcescens to polymyxin B. a comparative investigation of two S-form lipopolysaccharides obtained from a sensitive and a resistant variant of strain 111. J Endotoxin Res19963: 497-504.
102.
Lukácová M. , Kazár J., Gajdosová E., Vavreková M.Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging. FEMS Microbiol Lett1993; 113: 285-290.
Van Putten J.P.M., Robertson B.D.Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria. Mol Microbiol1995 ; 16: 847-853.
105.
Roche R.J., High N.J., Moxon E.R.Phase variation of Haemophilus influenzae lipopolysaccharide: Characterization of lipopolysaccharide from individual colonies. FEMS Microbiol Lett1994; 120: 279-284.
106.
Smith H., Parsons N.J., Cole J.A.Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity . Microb Pathog1995; 19: 365-377.
107.
Mandrell R.E. , McLaughlin R., Kwaik Y.A. et al. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated . Infect Immun1992; 60: 1322-1328.
108.
Mandrell R.E. , Lesse A., Sugai J.V. et al. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation . J Exp Med1990; 171: 1649-1664.
109.
Allen A., Maskell D.The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol Microbiol1996 ; 19: 37-52.
110.
Mikol V., Kosma P., Brade H.Crystal and molecular structure of allyl O-(sodium 3-deoxy-α-D-manno-2-octulopyranosylonate)-(2→8)-O-(sodium 3-deoxy-α-D-manno-2-octulopyranosidonate)-monohydrate. Carbohydr Res1994; 263: 35-42.
111.
Bundle D.R. , Young N.M.Carbohydrate-protein interactions in antibodies and lectins. Curr Opin Struct Biol1992 ; 2: 666-673.
112.
Cygler M., Rose D.R., Bundle D.R.Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody fab fragment. Science1991; 253: 442-445.
113.
Brade L., Brunnemann H., Ernst M. et al. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMSMed Microbiol Immunol1994 ; 8: 27-42.